Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Membrane-targeted peptides derived from Igalpha attenuate B-cell antigen receptor function.

Shara Kabak1, Marcus R Clark

  • 1Departments of Medicine and Pathology, Section of Rheumatology, Committee on Immunology, University of Chicago, Chicago, IL 60637, USA.

Biochemical and Biophysical Research Communications
|October 27, 2004
PubMed
Summary

Disrupting the B-cell antigen receptor (BCR) association with Src-family tyrosine kinases (SFTKs) using Igalpha/M or Igbeta/M analogs reduced BCR signaling. Igalpha/M specifically attenuated tyrosine phosphorylation and apoptosis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Autoreactive antibody production by intrarenal B cells in mouse kidney allograft rejection.

bioRxiv : the preprint server for biology·2026
Same author

Generalizations of the Jaccard index and Sørensen index for assessing agreement across multiple readers in object detection and instance segmentation in biomedical imaging.

Journal of medical imaging (Bellingham, Wash.)·2026
Same author

Deep profiling of lupus nephritis kidneys reveals dynamic changes in myeloid cells associated with disease progression.

Annals of the rheumatic diseases·2026
Same author

High-dimensional spatial proteomics and novel machine learning pipeline identifies disease specific renal damage states.

bioRxiv : the preprint server for biology·2026
Same author

Spatial Proximity Sequencing Maps Developmental Dynamics in the Germinal Center.

bioRxiv : the preprint server for biology·2025
Same author

Virtual multiplex immunofluorescence identifies lymphocyte subsets predictive of response to neoadjuvant therapy.

Therapeutic advances in medical oncology·2025

Area of Science:

  • Immunology
  • Cell Signaling
  • Molecular Biology

Background:

  • The B-cell antigen receptor (BCR) complex, comprising Igalpha/Igbeta heterodimers, is crucial for coupling receptor engagement to intracellular signaling pathways.
  • In resting B cells, Igalpha associates with Src-family tyrosine kinases (SFTKs), which possess basal activity essential for initiating signaling cascades upon receptor activation.

Purpose of the Study:

  • To investigate the role of the resting BCR complex in receptor activity by testing the hypothesis that disrupting Igalpha/Igbeta association with SFTKs would attenuate both basal and induced receptor functions.
  • To evaluate the effects of non-phosphorylatable analogs of Igalpha (Igalpha/M) and Igbeta (Igbeta/M) on BCR signaling and cellular responses.

Main Methods:

  • Expression of membrane-targeted, non-phosphorylatable analogs of Igalpha (Igalpha/M) and Igbeta (Igbeta/M) in B lymphocytes.

Related Experiment Videos

  • Assessment of BCR-induced calcium mobilization and tyrosine phosphorylation.
  • Evaluation of receptor-induced and basal apoptosis in an immature B-cell line.
  • Main Results:

    • Both Igalpha/M and Igbeta/M analogs inhibited BCR-induced calcium mobilization.
    • Only the Igalpha/M analog significantly diminished BCR-associated tyrosine phosphorylation.
    • Igalpha/M attenuated both receptor-induced and basal apoptosis in the immature B-cell line.

    Conclusions:

    • The resting state association between the BCR complex and SFTKs is critical for both basal and induced receptor activity.
    • Targeting the Igalpha subunit's interaction with SFTKs offers a potential therapeutic strategy for modulating BCR-mediated functions, including apoptosis.